News by topic

Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Hepatitis B news

Show

From To
Hepatitis B
High maternal viral load key to vertical transmission of hepatitis B

High maternal viral load is the most important factor causing maternally transmitted hepatitis B virus (HBV) infection and is significantly correlated with e antigen (HBeAg) positivity, according to a prospective study from Taiwan.

Published
19 March 2013
From
Medscape (requires registration)
Hepatitis C symptoms and diagnosis
Expanding High Risk Population Drives European Hepatitis B and C Diagnostics Market

New analysis from Frost & Sullivan, Analysis of the European Hepatitis B and C Diagnostics Market, estimates revenues of the hepatitis B diagnostics to grow from $165.9 million in 2012 to $260.2 million in 2019 and hepatitis C diagnostics market to grow from $3,140.8 million in 2012 to $4,940.9 million in 2019, respectively.

Published
13 March 2013
From
PR Newswire (press release)
Medical procedures and other blood-borne exposure
NY aims to prevent unsafe injections

The Safe Injection Practices Coalition, a group of healthcare-related organizations including the CDC indicated since 2001, more than 150,000 patients in the U.S. were told they may have been exposed to hepatitis B, hepatitis C, or human immunodeficiency virus because providers followed unsafe injection procedures.

Published
12 March 2013
From
UPI.com
Hepatitis B
Dually active antiretroviral therapy protects against hepatitis B infection

Use of antiretroviral therapy that includes drugs active against both hepatitis B virus (HBV) and HIV reduces the risk that people living with HIV will become infected

Published
07 March 2013
By
Liz Highleyman
Hepatitis B
Arrowhead data demonstrates RNAi candidate ARC-520 silences hepatitis B virus

Single injection induces multi-log repression of viral RNA, proteins, and viral DNA; Long duration of effect lasting over 30 days; Regulatory submissions planned for Q2 2013.

Published
27 February 2013
From
Arrowhead Research Corp press release
Hepatitis B
FDA rejects Dynavax's adult hepatitis B vaccine on safety concerns

U.S. health regulators denied approval for Dynavax Technologies Inc's adult hepatitis B vaccine pending additional data to evaluate its safety, potentially delaying the U.S. market entry of the company's first promising product.

Published
26 February 2013
From
Reuters
EASL publishes first comprehensive literature review on the burden of liver disease in Europe

Key findings in the report suggest that alcohol consumption, viral hepatitis B and C and metabolic syndromes related to overweight and obesity are the leading causes of cirrhosis and primary liver cancer in Europe.

Published
22 February 2013
From
Eurekalert Inf Dis
Hepatitis C
Triple trouble: infection with hepatitis B increases risk of death for people with HIV and hepatitis C co-infection

Infection with hepatitis B virus (HBV) is associated with a poorer prognosis for people living with HIV who are co-infected with hepatitis C virus (HCV), Spanish investigators

Published
19 February 2013
By
Michael Carter
Hepatitis B
Combining tenofovir with FTC or 3TC boosts chances of HBV suppression for people co-infected with HIV

A study involving people co-infected with HIV and hepatitis B virus (HBV) shows that antiretroviral therapy that combines tenofovir with FTC or 3TC has the best chance

Published
19 February 2013
By
Michael Carter
Hepatitis B
Study: One-third of hepatitis B and C cases in Pakistan are preventable

Approximately one-third of all hepatitis B and C cases in Pakistan could be prevented by interventions directed towards a few modifiable risk factors, according to a recent study.

Published
14 February 2013
From
Vaccine News Daily (blog)
← First12345...7Next →

Filter by country